Antiviral peptides as promising therapeutic drugs

LCP Vilas Boas, ML Campos, RLA Berlanda… - Cellular and Molecular …, 2019 - Springer
While scientific advances have led to large-scale production and widespread distribution of
vaccines and antiviral drugs, viruses still remain a major cause of human diseases today …

[HTML][HTML] Alternatives to overcoming bacterial resistances: State-of-the-art

AC Rios, CG Moutinho, FC Pinto, FS Del Fiol… - Microbiological …, 2016 - Elsevier
Worldwide, bacterial resistance to chemical antibiotics has reached such a high level that
endangers public health. Presently, the adoption of alternative strategies that promote the …

Scorpion venom components as potential candidates for drug development

E Ortiz, GB Gurrola, EF Schwartz, LD Possani - Toxicon, 2015 - Elsevier
Scorpions are well known for their dangerous stings that can result in severe consequences
for human beings, including death. Neurotoxins present in their venoms are responsible for …

Antiviral peptides: identification and validation

G Agarwal, R Gabrani - International journal of peptide research and …, 2021 - Springer
Despite rapid advances in the human healthcare, the infection caused by certain viruses
results in high morbidity and mortality accentuate the importance for development of new …

A comprehensive review about the molecular structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insights into natural products against …

EM Saied, YA El-Maradny, AA Osman, AMG Darwish… - Pharmaceutics, 2021 - mdpi.com
In 2019, the world suffered from the emergence of COVID-19 infection, one of the most
difficult pandemics in recent history. Millions of confirmed deaths from this pandemic have …

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides

KCL Mulder, LA Lima, VJ Miranda, SC Dias… - Frontiers in …, 2013 - frontiersin.org
Cationic antimicrobial peptides (AMPs) and host defense peptides (HDPs) show vast
potential as peptide-based drugs. Great effort has been made in order to exploit their …

Antimicrobial peptides from scorpion venoms

PL Harrison, MA Abdel-Rahman, K Miller, PN Strong - Toxicon, 2014 - Elsevier
The need for new antimicrobial agents is becoming one of the most urgent requirements in
modern medicine. The venoms of many different species are rich sources of biologically …

Scorpion venom peptides with no disulfide bridges: a review

A Almaaytah, Q Albalas - Peptides, 2014 - Elsevier
Scorpion venoms are rich sources of biologically active peptides that are classified into
disulfide-bridged peptides (DBPs) and non-disulfide-bridged peptides (NDBPs). DBPs are …

A review of the antiviral activity of cationic antimicrobial peptides

UL Urmi, AK Vijay, R Kuppusamy, S Islam… - Peptides, 2023 - Elsevier
Viral epidemics are occurring frequently, and the COVID-19 viral pandemic has resulted in
at least 6.5 million deaths worldwide. Although antiviral therapeutics are available, these …

Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses

Q Li, Z Zhao, D Zhou, Y Chen, W Hong, L Cao, J Yang… - Peptides, 2011 - Elsevier
Outbreaks of SARS-CoV, influenza A (H5N1, H1N1) and measles viruses in recent years
have raised serious concerns about the measures available to control emerging and re …